For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development.
Recent Posts
- Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
- Trump tells Senate Republicans to send federal health insurance money ‘directly to the people’
- Flight cancelations to worsen next week if shutdown continues
- Too early to bet against AI trade, State Street suggests
- Consumers on edge as ACA ‘subsidy cliff’ looms: ‘Quite frankly, it’s terrifying’